Search

Search Constraints

You searched for: Author/Creator Shi, Yinghui

Search Results

1. 183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus. (April 2019)

4. CT-08 Safety and tolerability of omalizumab, a humanized anti-IgE monoclonal antibody in systemic lupus erythematosus (STOP LUPUS). (August 2018)

8. Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis. Issue 3 (25th August 2020)

9. Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus. Issue 11 (1st August 2022)

10. Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Issue 7 (8th May 2019)